中文English
ISSN 1001-5256 (Print)
ISSN 2097-3497 (Online)
CN 22-1108/R
Issue 6
Jun.  2015
Turn off MathJax
Article Contents

Significance of predictive models / risk calculators for HBV-related hepatocellular carcinoma

DOI: 10.3969/j.issn.1001-5256.2015.06.008
  • Published Date: 2015-06-20
  • Hepatitis B virus( HBV)- related hepatocellular carcinoma( HCC) is a major public health problem in Southeast Asia. In recent years,researchers from Hong Kong and Taiwan have reported predictive models or risk calculators for HBV- associated HCC by studying its natural history,which,to some extent,predicts the possibility of HCC development. Generally,risk factors of each model involve age,sex,HBV DNA level,and liver cirrhosis. This article discusses the evolution and clinical significance of currently used predictive models for HBV- associated HCC and assesses the advantages and limits of risk calculators. Updated REACH- B model and LSM- HCC model show better negative predictive values and have better performance in predicting the outcomes of patients with chronic hepatitis B( CHB). These models can be applied to stratified screening of HCC and,meanwhile,become an assessment tool for the management of CHB patients.

     

  • loading
  • [1]MITTAL S,El-SERAG HB.Epidemiology of hepatocellular carcinoma:consider the population[J].J Clin Gastroenterol,2013,47(Suppl):s2-s6.
    [2]WONG GL,WONG VW,TAN GM,et al.Surveillance programme for hepatocellular carcinoma improves the survival of patients with chronic viral hepatitis[J].Liver Int,2008,28(1):79-87.
    [3] BRUIX J,SHERMAN M.Management of hepatocellular carcinoma:an update[J].Hepatology,2011,53(3):1020-1022.
    [4]YUEN MF,TANAKA Y,FONG DY,et al.Independent risk factors and predictive score for the development of hepatocellular carcinoma in chronic hepatitis B[J].J Hepatol,2009,50(1):80-88.
    [5]YANG JD,KIM WR,COELHO R,et al.Cirrhosis is present in most patients with hepatitis B and hepatocellular carcinoma[J].Clin Gastroenterol Hepatol,2011,9(1):64-70.
    [6]HAN KH,AHN SH.How to predict HCC development in patients with chronic B viral liver disease?[J].Intervirology,2005,48(1):23-28.
    [7] WONG VW,CHAN SL,MO F,et al.Clinical scoring system to predict hepatocellular carcinoma in chronic hepatitis B carriers[J].J Clin Oncol,2010,28(10):1660-1665.
    [8]WONG GL,CHAN HL,WONG CK,et al.Liver stiffness-based optimization of hepatocellular carcinoma risk score in patients with chronic hepatitis B[J].J Hepatol,2014,60(2):339-345.
    [9]YANG HI,SHERMAN M,SU J,et al.Nomograms for risk of hepatocellular carcinoma in patients with chronic hepatitis B virus infection[J].J Clin Oncol,2010,28(14):2437-2244.
    [10]YANG HI,YUEB MF,CHAN HL,et al.Risk estimation for hepatocellular carcinoma in chronic hepatitis B(REACH-B):development and validation of a predictive score[J].Lancet Oncol,2011,12(6):568-574.
    [11]LEE MH,YANG HI,LIU J,et al.Prediction models of long-term cirrhosis and hepatocellular carcinoma risk in chronic hepatitis B patients:risk scores integrating host and virus profiles[J].Hepatology,2013,58(2):546-554.
    [12]PAPATHEODORIDIS GV,DALEKOS GN,YURDAYDIN C,et al.Incidence and predictors of hepatocellular carcinoma in Caucasian chronic hepatitis B patients receiving entecavir or tenofovir[J].J Hepatol,2015,62(2):363-370.
    [13]YANG HI,LEE MH,LIU J,et al.Risk calculators for hepatocellular carcinoma in patients affected with chronic hepatitis B in Asia[J].World J Gastroenterol,2014,20(20):6244-6251.
    [14]KAO JH.Risk stratification of HBV infection in Asia-Pacific region[J].Clin Mol Hepatol,2014,20(3):223-227.
    [15]WONG GL,CHAN HL,CHAN H,et al.Accuracy of risk scores for patients with chronic hepatitis B receiving entecavir treatment[J].Gastroenterology,2013,144(5):933-944.
    [16]COFFIN CS,REZAEEAVAL M,PANG JX,et al.The incidence of hepatocellular carcinoma is reduced in patients with chronic hepatitis B on long-term nucleos(t)ide analogue therapy[J].Aliment Pharmacol Ther,2014,40(11-12):1262-1269.
    [17]DONG J,JIANG JJ.Screening and the effect of antiviral therapy for hepatitis B virus related hepatocellular carcinoma[J].Chin J Viral Dis,2013,3(6):474-479.(in Chinese)董菁,江家骥.乙型肝炎病毒相关性肝细胞癌的筛查及抗病毒治疗的应用[J].中国病毒病杂志,2013,3(6):474-479.
  • 加载中

Catalog

    通讯作者: 陈斌, bchen63@163.com
    • 1. 

      沈阳化工大学材料科学与工程学院 沈阳 110142

    1. 本站搜索
    2. 百度学术搜索
    3. 万方数据库搜索
    4. CNKI搜索

    Article Metrics

    Article views (2857) PDF downloads(573) Cited by()
    Proportional views
    Related

    /

    DownLoad:  Full-Size Img  PowerPoint
    Return
    Return